The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-fluoro-2-(1-(2-fluoro-3-methylbenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4-ol ID: ALA3810301
PubChem CID: 71621106
Max Phase: Preclinical
Molecular Formula: C18H13F2N5O2
Molecular Weight: 369.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(Cn2nc(-c3ncc(F)c(O)n3)cc2-c2ccon2)c1F
Standard InChI: InChI=1S/C18H13F2N5O2/c1-10-3-2-4-11(16(10)20)9-25-15(13-5-6-27-24-13)7-14(23-25)17-21-8-12(19)18(26)22-17/h2-8H,9H2,1H3,(H,21,22,26)
Standard InChI Key: VQPILUYEENTSEO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
6.2524 -0.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4979 1.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0317 0.7359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2526 -1.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5610 -2.8305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6461 -3.9967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4977 -5.2315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9352 -4.8031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9720 -3.3035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1035 2.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5736 2.6979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0739 4.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0995 5.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6247 4.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1243 3.5645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8451 5.8909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4998 6.3836 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
5 6 1 0
4 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
2 18 1 0
22 24 1 0
21 25 1 0
17 26 1 0
16 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.33Molecular Weight (Monoisotopic): 369.1037AlogP: 3.34#Rotatable Bonds: 4Polar Surface Area: 89.86Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.79CX Basic pKa: ┄CX LogP: 4.38CX LogD: 4.38Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.59Np Likeness Score: -1.64
References 1. Nakai T, Perl NR, Barden TC, Carvalho A, Fretzen A, Germano P, Im GY, Jin H, Kim C, Lee TW, Long K, Moore J, Rohde JM, Sarno R, Segal C, Solberg EO, Tobin J, Zimmer DP, Currie MG.. (2016) Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans., 7 (5): [PMID:27190594 ] [10.1021/acsmedchemlett.5b00479 ]